心脏代谢性慢性疾病:肥胖与血糖异常驱动因素(JACC 前沿综述)
本文提出心脏代谢性慢性疾病(CMBCD)新模型,以遗传、环境、行为为原发驱动因素,以肥胖和血糖异常为代谢驱动因素,并对应冠心病、心力衰竭和心房颤动三个心血管终点。模型旨在明确可干预靶点,为早期、可持续的循证治疗提供框架,以促进心脏代谢健康并减轻心血管疾病的发生与危害。
要点
- CMBCD模型聚焦遗传、环境、行为三个原发驱动因素与肥胖、血糖异常两个代谢驱动因素。
- 代谢驱动因素通过胰岛素抵抗、β细胞功能障碍和代谢综合征等机制导致心血管疾病。
- 模型对应冠心病、心力衰竭和心房颤动三个心血管终点,旨在暴露可干预的预防靶点。
核心结论
- 提出CMBCD模型,为早期、可持续的循证治疗提供框架,以促进心脏代谢健康并减轻心血管疾病的发生与危害。
研究设计与样本
- JACC前沿综述,提出CMBCD模型框架,聚焦3个原发驱动因素和2个代谢驱动因素,对应3个心血管终点。
主要发现
- 原发驱动因素(遗传、环境、行为)与后续肥胖、胰岛素抵抗、β细胞功能障碍和代谢综合征配置特定机制通路,导致心血管疾病。
临床怎么用
- 利用CMBCD模型识别可干预靶点,为早期预防和可持续的循证治疗提供依据,以改善心血管结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A new cardiometabolic-based chronic disease (CMBCD) model is presented that provides a basis for early and sustainable, evidence-based therapeutic targeting to promote cardiometabolic health and mitigate the development and ravages of cardiovascular disease. In the first part of this JACC State-of-the-Art Review, a framework is presented for CMBCD, focusing on 3 primary drivers (genetics, environment, and behavior) and 2 metabolic drivers (adiposity and dysglycemia) with applications to 3 cardiovascular endpoints (coronary heart disease, heart failure, and atrial fibrillation). Specific mechanistic pathways are presented configuring early primary drivers with subsequent adiposity, insulin resistance, β-cell dysfunction, and metabolic syndrome, leading to cardiovascular disease. The context for building this CMBCD model is to expose actionable targets for prevention to achieve optimal cardiovascular outcomes. The tactical implementation of this CMBCD model is the subject of second part of this JACC State-of-the-Art Review.
引用
- Mechanick JI, Farkouh ME, Newman JD, et al. Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020. PMID: 32029136. doi:10.1016/j.jacc.2019.11.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。